======= NMNAT1 =======
== Gene Information ==
* **Official Symbol**: NMNAT1
* **Official Name**: nicotinamide nucleotide adenylyltransferase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64802|64802]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9HAN9|Q9HAN9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NMNAT1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NMNAT1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608700|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes an enzyme which catalyzes a key step in the biosynthesis of nicotinamide adenine dinucleotide (NAD). The encoded enzyme is one of several nicotinamide nucleotide adenylyltransferases, and is specifically localized to the cell nucleus. Activity of this protein leads to the activation of a nuclear deacetylase that functions in the protection of damaged neurons. Mutations in this gene have been associated with Leber congenital amaurosis 9. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are located on chromosomes 1, 3, 4, 14, and 15. [provided by RefSeq, Jul 2014].
* **UniProt Summary**: N/A
|CTP transf 2|
|negative regulation of apoptotic DNA fragmentation|
|nicotinamide-nucleotide adenylyltransferase activity|
|ATP generation from poly-ADP-D-ribose|
|nicotinate-nucleotide adenylyltransferase activity|
|negative regulation of DNA catabolic process|
|regulation of apoptotic DNA fragmentation|
|regulation of DNA catabolic process|
|negative regulation of execution phase of apoptosis|
|NAD biosynthetic process|
|pyridine nucleotide biosynthetic process|
|nicotinamide nucleotide biosynthetic process|
|nicotinamide nucleotide metabolic process|
|pyridine nucleotide metabolic process|
|pyridine-containing compound biosynthetic process|
|regulation of execution phase of apoptosis|
|pyridine-containing compound metabolic process|
|NAD metabolic process|
|oxidoreduction coenzyme metabolic process|
|negative regulation of DNA metabolic process|
|coenzyme biosynthetic process|
|negative regulation of neuron apoptotic process|
|ATP metabolic process|
|regulation of neuron apoptotic process|
|negative regulation of neuron death|
|cofactor biosynthetic process|
|nucleotide biosynthetic process|
|nucleoside phosphate biosynthetic process|
|coenzyme metabolic process|
|negative regulation of cellular catabolic process|
|nuclear body|
|negative regulation of catabolic process|
|regulation of neuron death|
|regulation of DNA metabolic process|
|cofactor metabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|organophosphate biosynthetic process|
|nucleobase-containing small molecule metabolic process|
|positive regulation of MAPK cascade|
|response to wounding|
|negative regulation of cellular component organization|
|regulation of MAPK cascade|
|regulation of cellular catabolic process|
|organophosphate metabolic process|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|regulation of catabolic process|
|negative regulation of cell death|
|positive regulation of protein phosphorylation|
|positive regulation of intracellular signal transduction|
|carbohydrate derivative metabolic process|
|positive regulation of phosphorylation|
|identical protein binding|
|nucleobase-containing compound biosynthetic process|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|positive regulation of protein modification process|
|organic cyclic compound biosynthetic process|
|organonitrogen compound biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|regulation of protein phosphorylation|
|ATP binding|
|regulation of apoptotic process|
|regulation of programmed cell death|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|cellular nitrogen compound biosynthetic process|
|positive regulation of signal transduction|
|regulation of cell death|
|positive regulation of protein metabolic process|
|small molecule metabolic process|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp279|D-Fructose 10000μM R06 exp279]]|-2.2|
|[[:results:exp29|Rapamycin 1μM R00 exp29]]|-2.15|
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|-2.09|
|[[:results:exp20|Etoposide 10μM R00 exp20]]|-2.07|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.85|
|[[:results:exp293|Myriocin 25μM R06 exp293]]|-1.73|
|[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-1.73|
|[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-1.72|
|[[:results:exp481|Ethambutol 25μM R08 exp481]]|1.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 54/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|5/28|
|bone|1/26|
|breast|2/33|
|central nervous system|4/56|
|cervix|1/4|
|colorectal|1/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|1/16|
|kidney|0/21|
|liver|0/20|
|lung|4/75|
|lymphocyte|7/16|
|ovary|1/26|
|pancreas|1/24|
|peripheral nervous system|0/16|
|plasma cell|4/15|
|prostate|0/1|
|skin|3/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 521
* **Expression level (log2 read counts)**: 4.53
{{:chemogenomics:nalm6 dist.png?nolink |}}